A while back, Mike Huckman at the CNBC Pharma’s Market blog wrote about the opinions of Dr. Roy Vagelos, the former CEO of Merick. His beliefs on the current state of drug prices were quite contradictory to what we usually hear coming out of the drug industry.
"There is a shocking disparity between value and price and it's not sustainable. The industry will bring about government price controls which will be devastating for the industry."
Do you find this to be true? What do you think?
No comments:
Post a Comment